← back to search

Viviane M. Andrade

Inovio Pharmaceuticals (United States) · BR
Area of research
Infectious Diseases · Immunology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses, vaccines and immunoinformatics approaches, and COVID-19 Clinical Research Studies.
h-index
15
citations
1,735
works
39
NIH funding
primary concept
email

Recent publications

Immunogenicity of a DNA vaccine candidate for COVID-19
Nature Communications 2020cited by 639position: middledoi
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption
Proceedings of the National Academy of Sciences 2020cited by 74position: firstdoi
Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells
Journal of Virology 2020cited by 65position: middledoi
Host and Viral Factors Influencing Interplay between the Macrophage and HIV-1
Journal of Neuroimmune Pharmacology 2018cited by 19position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Mario Stevenson · University of Miami3 papers (2018–2020) · 1 papers (2020–2020)Hyeryun Choe · Scripps Institution of Oceanography1 papers (2020–2020)Logan Barrios · University of Utah1 papers (2020–2020)Thaissa Isaias Cordeiro · Universidade Federal Fluminense1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2020–2020)Carla Mavian · University of Florida1 papers (2020–2020) · 1 papers (2020–2020)Marco Salemi · University of Florida1 papers (2020–2020) · 1 papers (2020–2020)Shanel Tsuda · Virginia Tech1 papers (2020–2020)Jonathan Z. Li · Harvard University1 papers (2020–2020) · 1 papers (2020–2020)Michael D. Cameron · Scripps Research Institute1 papers (2020–2020)Jeffrey M. Jacobson · University Hospitals of Cleveland1 papers (2020–2020)Joseph Jablonski · Scripps Institution of Oceanography1 papers (2020–2020) · 1 papers (2020–2020)Dunja Z. Babič · University of Split1 papers (2020–2020)Avik Biswas · Salk Institute for Biological Studies1 papers (2020–2020)